Recent advances in dual-drug co-amorphous systems

被引：9
|
作者：
Shelke, Rutuja [1 ]
Velagacherla, Varalakshmi [1 ]
Nayak, Usha Yogendra [1 ]
机构：
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut, Manipal 576104, Karnataka, India
来源：
DRUG DISCOVERY TODAY | 2024年 / 29卷 / 02期
关键词：
solubility; co-amorphous systems; dual-drug co-amorphous systems; molecular modelling; crystalline drugs; stability; amorphous drugs; docking models; crystalline inhibitors; IN-VIVO BIOAVAILABILITY; PHYSICOCHEMICAL PROPERTIES; PHYSICAL STABILITY; ENHANCED DISSOLUTION; ORAL BIOAVAILABILITY; COAMORPHOUS SYSTEM; DELIVERY SYSTEMS; CLASSIFICATION; COMBINATIONS; RITONAVIR;
D O I：
10.1016/j.drudis.2023.103863
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Poor solubility of drugs and therapeutic candidates poses a significant challenge in drug research and development. Biopharmaceutical class II drugs exhibit limited absorption because of their weak solubility and high permeability. Co-amorphous systems (CAMs) have been studied widely as a way to improve the solubility of drugs. This review summarizes recent advancements in dual-drug CAMs, including improvements in formulation, manufacturing, and solid-state characterization, and highlights the importance of enhancing solubility and stability. It emphasizes the potential synergistic effects of two drugs in CAMs and explores formulation strategies and challenges related to maintaining the amorphous state. Case studies demonstrate the successful application of CAMs in combination therapies that offer improved therapeutic efficacy.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems
    Wu, Wenqi
    Lobmann, Korbinian
    Rades, Thomas
    Grohganz, Holger
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 535 (1-2) : 86 - 94
  • [22] The influence of moisture on the storage stability of co-amorphous systems
    Liu, Jingwen
    Rades, Thomas
    Grohganz, Holger
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 605
  • [23] Preparation of Co-Amorphous Systems by Freeze-Drying
    Wostry, Melvin
    Plappert, Hanna
    Grohganz, Holger
    PHARMACEUTICS, 2020, 12 (10) : 1 - 12
  • [24] Preparation of Co-Amorphous Levofloxacin Systems for Pulmonary Application
    Gabelmann, Aljoscha
    Lehr, Claus-Michael
    Grohganz, Holger
    PHARMACEUTICS, 2023, 15 (06)
  • [25] Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs
    Wang, Hongge
    Zhao, Peixu
    Ma, Ruilong
    Jia, Jirun
    Fu, Qiang
    DRUG DISCOVERY TODAY, 2024, 29 (02)
  • [26] Evaluation of Drug Dissolution Rate in Co-amorphous and Co-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods
    Hu, Chunhui
    Zhang, Fabin
    Fan, Haining
    AAPS PHARMSCITECH, 2021, 22 (01)
  • [27] Evaluation of Drug Dissolution Rate in Co-amorphous and Co-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods
    Chunhui Hu
    Fabin Zhang
    Haining Fan
    AAPS PharmSciTech, 22
  • [28] Indomethacin co-amorphous drug-drug systems with improved solubility, supersaturation, dissolution rate and physical stability
    Fael, Hanan
    Demirel, A. Levent
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 600
  • [29] Mechanism for Stabilizing an Amorphous Drug Using Amino Acids within Co-Amorphous Blends
    Guinet, Yannick
    Paccou, Laurent
    Hedoux, Alain
    PHARMACEUTICS, 2023, 15 (02)
  • [30] Design and molecular insights of drug-active metabolite based co-amorphous formulation: A case study of toltrazuril-ponazuril co-amorphous
    Li, Bin
    Wang, Yingyun
    Feng, Ying
    Yuan, Dan
    Xu, Renjie
    Jiang, Cuiping
    Xiao, Xuecheng
    Lu, Shan
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 615
12345